RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection

Elisa Gremese; Stefano Alivernini; Gianfranco Ferraccioli

doi:10.1073/pnas.2025609118

RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection

Elisa Gremese
, Stefano Alivernini
, Gianfranco Ferraccioli

Research output: Contribution to journal › Article

Abstract

Not applicable

Original language	English
Pages (from-to)	N/A-N/A
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	118
DOIs	https://doi.org/10.1073/pnas.2025609118
Publication status	Published - 2021

Keywords

Angiotensin-Converting Enzyme Inhibitors
Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
COVID-19
Humans
Hypoglycemic Agents
Renin-Angiotensin System
SARS-CoV-2

Access to Document

10.1073/pnas.2025609118

Cite this

@article{f69b5e46399244f79335714006ad296c,

title = "RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection",

abstract = "Not applicable",

keywords = "Angiotensin-Converting Enzyme Inhibitors, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, COVID-19, Humans, Hypoglycemic Agents, Renin-Angiotensin System, SARS-CoV-2, Angiotensin-Converting Enzyme Inhibitors, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, COVID-19, Humans, Hypoglycemic Agents, Renin-Angiotensin System, SARS-CoV-2",

author = "Elisa Gremese and Stefano Alivernini and Gianfranco Ferraccioli",

year = "2021",

doi = "10.1073/pnas.2025609118",

language = "English",

volume = "118",

pages = "N/A--N/A",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

}

TY - JOUR

T1 - RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection

AU - Gremese, Elisa

AU - Alivernini, Stefano

AU - Ferraccioli, Gianfranco

PY - 2021

Y1 - 2021

N2 - Not applicable

AB - Not applicable

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Anti-Inflammatory Agents, Non-Steroidal

KW - Anticoagulants

KW - COVID-19

KW - Humans

KW - Hypoglycemic Agents

KW - Renin-Angiotensin System

KW - SARS-CoV-2

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Anti-Inflammatory Agents, Non-Steroidal

KW - Anticoagulants

KW - COVID-19

KW - Humans

KW - Hypoglycemic Agents

KW - Renin-Angiotensin System

KW - SARS-CoV-2

UR - http://hdl.handle.net/10807/197061

U2 - 10.1073/pnas.2025609118

DO - 10.1073/pnas.2025609118

M3 - Article

SN - 0027-8424

VL - 118

SP - N/A-N/A

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

ER -

RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this